InvestorsHub Logo

eastunder

12/05/10 11:09 PM

#916 RE: ScovilleUnits #915

Verrrrrrrrrrrrrrrrrry interesting.

eastunder

12/08/10 1:40 PM

#917 RE: ScovilleUnits #915

Moving back to 2005 numbers (R split adjusted of course)

Since 1 for 2 reverse split 7-21-09

http://www.knobias.com/story.htm?eid=3.1.daef7a2443e4e2e587d5664cd0019b2669031bc1b5e0ade01dae5946dccbe559





eastunder

01/20/11 9:25 AM

#919 RE: ScovilleUnits #915

Karen Signer’s remains at 24% ownership of EVOL

SCHEDULE 13D filed: w/Time frame extended on Confidentiality agreement

http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=7343769

This constitutes Amendment No. 12 (the “Amendment No. 12”) to the Statement on Schedule 13D, filed on behalf of Karen Singer (“Ms. Singer”), dated February 28, 2008 (the “Statement”), relating to the common stock (the “Common Stock”) of Evolving Systems, Inc., a Delaware corporation (the “Issuer” or “Company”). Unless specifically amended or modified hereby, the disclosure set forth in the Statement shall remain unchanged.
Item 4. Purpose of the Transaction.
Item 4 of the Statement is hereby amended by adding the following at the end thereof:

On November 26, 2010, Ms. Singer entered into a Confidentiality Agreement, in the form filed as Exhibit 99.1 to the Schedule 13D filed on December 1, 2010 (the “November Confidentiality Agreement”), by and among the Issuer and Ms. Singer. Effective January 15, 2011, the November Confidentiality Agreement was amended to extend the period during which it remains effective so that, as amended, the November Confidentiality Agreement remains in effect until January 31, 2011.

Except as described above in this Item 4 and herein, Ms. Singer does not currently have any specific plans or proposals that relate to or would result in any of the actions or events specified in clauses (a) through (j) of Item 4 of Schedule 13D. Ms. Singer reserves the right to change plans and take any and all actions that Ms. Singer may deem appropriate to maximize the value of her investments, including, among other things, purchasing or otherwise acquiring additional securities of the Issuer, selling or otherwise disposing of any securities of the Issuer beneficially owned by her, in each case in the open market or in privately negotiated transactions, or formulating other plans or proposals regarding the Issuer or its securities to the extent deemed advisable by Ms. Singer in light of her general investment policies, market conditions, subsequent developments affecting the Issuer and the general business and future prospects of the Issuer. Ms. Singer may take any other action with respect to the Issuer or any of the Issuer’s debt or equity securities in any manner permitted by applicable law.